DOI: 10.62211/82ej-91yt Liraglutide has a C16 palmitoyl fatty acid at lysine-26 via a short linker, binding albumin, extending its half-life from under 2 minutes to 11-15 hours, now allowing for once-daily dosing
This article will explore: What these drugs doand what they dont Where the science is solidand where it isnt How cultural euphoria can outpace clinical understanding And what it really means to lose weight when hunger is no longer part of the story Because in the end, this isnt just about one drug or one disease
A recent genome-wide association study also identified the gene NBEA (neurobeachin) as likely contributing to differences in weight loss on GLP-1s
The exercise arm involved supervised group sessions with heart rate monitoring
The success of orforglipron is even more impressive considering that some competitor small-molecule GLP-1RAs have not progressed
Christensen, S., Robinson, K., Thomas, S., & Williams, D